» Articles » PMID: 22157623

Liver Fibrosis: Mechanisms of Immune-mediated Liver Injury

Overview
Date 2011 Dec 14
PMID 22157623
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Liver fibrosis and its end-stage consequence, cirrhosis, represent the final common pathway of virtually all chronic liver diseases. Research into hepatic stellate cell activation, imbalance of the extracellular matrix synthesis and degradation and the contribution of cytokines and chemokines has further elucidated the mechanisms underlying fibrosis. Furthermore, clarification of changes in host adaptive and innate immune systems has accelerated our understanding of the association between liver inflammation and fibrosis. Continued elucidation of the mechanisms of hepatic fibrosis has provided a comprehensive model of fibrosis progression and regression. This review summarizes the current concepts of improvements that have been made in the field of fibrosis.

Citing Articles

Impact of liver fibrosis on AAV-mediated gene transfer to mouse hepatocytes.

Ferriero R, Bruno G, Padula A, Pisano S, Boffa I, Gargaro M Nat Commun. 2025; 16(1):2118.

PMID: 40064861 PMC: 11893804. DOI: 10.1038/s41467-025-57382-9.


Single-cell RNA sequencing and functional analysis reveal the role of altered glycosylation levels of hepatic macrophages in liver cirrhosis.

Wen C, Tao H, Chen H, Pu W, Yan Q, Zou Y J Gastroenterol. 2025; .

PMID: 39888412 DOI: 10.1007/s00535-025-02218-y.


The role of ferroptosis-related non-coding RNA in liver fibrosis.

Zhang G, Wu K, Jiang X, Gao Y, Ding D, Wang H Front Cell Dev Biol. 2024; 12:1517401.

PMID: 39717848 PMC: 11663870. DOI: 10.3389/fcell.2024.1517401.


Dietary contributions in the genetic variation of liver fibrosis: a genome-wide association study of fibrosis-4 index in the liver fibrosis development.

Palupi P, Wei C, Chou W, Lin M, Wan Y, Chang W Cell Biosci. 2024; 14(1):141.

PMID: 39578894 PMC: 11583755. DOI: 10.1186/s13578-024-01321-6.


Rejuvenating bone marrow hematopoietic reserve prevents regeneration failure and hepatic decompensation in animal model of cirrhosis.

Nautiyal N, Maheshwari D, Kumar D, Rao E, Tripathi D, Kumar S Front Immunol. 2024; 15:1439510.

PMID: 39188716 PMC: 11345600. DOI: 10.3389/fimmu.2024.1439510.


References
1.
Gressner A, Weiskirchen R . Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006; 10(1):76-99. PMC: 3933103. DOI: 10.1111/j.1582-4934.2006.tb00292.x. View

2.
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y . Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 1997; 272(4):2446-51. DOI: 10.1074/jbc.272.4.2446. View

3.
Benyon R, Iredale J, Goddard S, Winwood P, Arthur M . Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology. 1996; 110(3):821-31. DOI: 10.1053/gast.1996.v110.pm8608892. View

4.
Fattovich G, GIUSTINA G, Degos F, Tremolada F, Diodati G, Almasio P . Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997; 112(2):463-72. DOI: 10.1053/gast.1997.v112.pm9024300. View

5.
Novobrantseva T, Majeau G, Amatucci A, Kogan S, Brenner I, Casola S . Attenuated liver fibrosis in the absence of B cells. J Clin Invest. 2005; 115(11):3072-82. PMC: 1265860. DOI: 10.1172/JCI24798. View